Search Results

You searched for : Saroglitazar

	Top Ten Pharma Companies of India : January 2021 Top ten pharma stocks January 2021... Jan 06
	Zydus announces the approval of Saroglitazar Mg for the treatment of Non-Alcoholic fatty Liver disease in India About 25 to 30% of Indian population suffers from NALD... Dec 30
	Zydus granted fast track designation by the USFDA for Saroglitazar in the treatment of patients with PBC Fast Track is a process of the USFDA which expedites the review of drugs to treat serious conditions and fill an unmet medical need... Dec 09
	Zydus Announces Worldâ€™s First Drug for the Treatment of Non-Cirrhotic NASH Saroglitazar, approved by DCGI becomes the first ever drug anywhere in the world for treatment of Non-Cirrhotic Non-Alcoholic SteatoHepatitis (NASH). NASH ranks as ... Mar 06
	Zydus receives approval from DCGI for Saroglitazar Magnesium for treatment of Type II Diabetes Zydusâ€™ Saroglitazar Magnesium has been approved for the treatment of diabetes mellitus type 2 by the Drug Controller General of India ... Feb 07
	Zydus Cadilaâ€™s Net Profit up by 18% in Q3 on a sequential basis Zydus Cadila's net profit excluding exceptional items for the quarter was up 18% q-o-q to Rs. 375 crores.... Feb 07
6 Matching result(s) found!

-Advertisements-

Trending Now
	Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
	International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
	The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
	Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
	Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
	In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
	Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
	Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
	10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
	Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
	The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
	Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
	A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
	The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
	ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
	The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
	Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
	Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
	AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
	Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024

Search Results

Top Ten Pharma Companies of India : January 2021

Zydus announces the approval of Saroglitazar Mg for the treatment of Non-Alcoholic fatty Liver disease in India

Zydus granted fast track designation by the USFDA for Saroglitazar in the treatment of patients with PBC

Zydus Announces Worldâ€™s First Drug for the Treatment of Non-Cirrhotic NASH

Zydus receives approval from DCGI for Saroglitazar Magnesium for treatment of Type II Diabetes

Zydus Cadilaâ€™s Net Profit up by 18% in Q3 on a sequential basis

Trending Now